About
Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.
Technologies
NSOne
Outlook
Microsoft Office 365
Squarespace ECommerce
Mobile Friendly
Keywords
medical devices endovascular dialysis access peripheral artery disease
medical equipment manufacturing
vascular revascularization
long-term patient outcomes
interventional cardiology
vascular stent graft
drug-eluting technology
stent platform
electrospinning ptfe membrane
edge stenosis
biodegradable polymers
vascular device innovation
sirolimus
peripheral artery treatment
vascular restenosis prevention
target lesion revascularization
vascular health
target lesion patency
ptfe covered stent
medical device
vascular grafts
b2b
vascular intervention
biocompatible barrier
drug delivery system
blood flow restoration
minimally invasive treatment
vascular disease management
endovascular solutions
sirolimus coating
Company Information
-
Employees 3
-
Founded 2024
Location
201 Saint Charles Avenue, New Orleans, Louisiana, United States, 70170
